ð¬ Current Disease Focus:
Task Progress: 0%
ð¥ Active Problem Solvers
0
ð Experts collaborating globally
â¡ Current Task Assignment
𧬠Genetic Analysis
ð Matching experts to specific tasks
ð Resource Allocation by Research Phase:
ð Data Analysis
𧪠Experimental Design
ð¬ Clinical Trials
ð Treatment Development
The objective of this study is to evaluate the impact of reduced pump prime...
Status
Terminated
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00646373
Treatments Being Tested
70 subjects received BCG intradermally at Study Day -42, then at Study Day ...
Status
Completed
Location
Centre Hosptialier Universitaire Vaudois (CHUV)
Start Date
2011-01
Trial ID
NCT02420444
The purpose of this study is to determine whether albumin administration du...
Status
Terminated
Location
Adult Intensive Care Unit, Royal Brompton and Harefield NHS Trust
Start Date
2008-12
Trial ID
NCT00773110
Treatments Being Tested
The purpose of this study is to determine whether acadesine is effective in...
Status
Terminated
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00872001
Treatments Being Tested
Microlyvaq⢠is a first-line, non-randomized, two-arm clinical trial in adva...
Status
Enrolling By Invitation
Location
Biogenea Pharmaceuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07285434
Treatments Being Tested
Rationale: Contemporary coronary artery bypass grafting (CABG) continues t...
Status
Completed
Location
Dep. of Cardiothoracic Surgery, Aarhus University Hospital
Start Date
2017-09-28
Trial ID
NCT03216720
Treatments Being Tested
Hemodilution reduces concentrations of blood constituents: concentration of...
Status
Withdrawn
Location
Hamilton General Hospital
Start Date
2022-09-21
Trial ID
NCT04870073
Treatments Being Tested
This is a single centre, randomized, placebo-controlled phase 1/2 study com...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-01
Trial ID
NCT05441410
The purpose of this study is to evaluate the safety, tolerability, and the ...
Status
Completed
Location
Celerion Inc.
Start Date
2019-02-28
Trial ID
NCT03929172
Interferon (IFN) lambda is one of the fundamental responses of the innate i...
Status
Unknown
Location
Toronto General Hospital
Start Date
2021-08-27
Trial ID
NCT04967430
Treatments Being Tested